Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
about
Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis.Effects of Zoledronate on Mortality and Morbidity after Surgical Treatment of Hip Fractures.Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.A model of fracture risk used to examine the link between bone mineral density and the impact of different therapeutic mechanisms on fracture outcomes in patients with osteoporosis.Response to the American College of Physicians Osteoporosis Guideline, 2017 Update.
P2860
Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
@en
Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
@nl
type
label
Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
@en
Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
@nl
prefLabel
Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
@en
Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
@nl
P2093
P2860
P356
P1476
Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women.
@en
P2093
P2860
P304
P356
10.1177/0300060513480917
P577
2013-05-13T00:00:00Z